Skip to content
DataLookout
Menu

NCT02725060

Autoimmune Basis for Postural Tachycardia Syndrome

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 19 versions: 16 with changes below, 3 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 18 words
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    • Primary completion pushed from Oct 2026 to Feb 2027
    • Study completion pushed from Dec 2026 to Jun 2027
  2. Notable Primary completion date: Oct 2025 to Oct 2026
    • Study completion date: Dec 2025 to Dec 2026
    v18
  3. Notable Primary completion date: Oct 2024 to Oct 2025
    • Study completion date: Dec 2024 to Dec 2025
    v17
  4. Notable Primary completion date: Oct 2023 to Oct 2024
    • Study completion date: Dec 2023 to Dec 2024
    v15
  5. Minor Primary completion date: Apr 2023 to Oct 2023
    • Study completion date: Jul 2023 to Dec 2023
    v14
Show 10 earlier versionsHide 10 earlier versions
  1. Notable Primary completion date: Apr 2022 to Apr 2023
    • Study completion date: Jul 2022 to Jul 2023
    v12
  2. Notable Primary completion date: Apr 2021 to Apr 2022
    • Study completion date: Jul 2021 to Jul 2022
    v11
  3. Minor Primary completion date: Oct 2020 to Apr 2021
    • Study completion date: Dec 2020 to Jul 2021
    v10
  4. Notable Trial status: Suspended to Enrolling by Invitationv9
  5. Stopped Trial status: Active, Not Recruiting to Suspended Sponsor's reason: Recruitment is temporarily suspended due to COVID-19 outbreak
    • Primary completion date: Feb 2020 to Oct 2020
    • Study completion date: Jul 2020 to Dec 2020
    v8
  6. Minor Trial status: Recruiting to Active, Not Recruitingv7 Show 4 more changesShow less
    • Enrollment target: estimated 95 to confirmed 58
    • Primary completion date: Feb 2021 to Feb 2020
    • Study completion date: Jul 2021 to Jul 2020
    • Site details revised at 2 of 2 sites
  7. Minor Site contacts updated at 1 of 2 sitesv6
  8. Minor Interventions: 24-hour heart rhythm and blood pressure monitoring (Procedure), 25 micro-Ci of radiation (Radiation), Autonomic function tests (Procedure)… to 24-hour heart rhythm and blood pressure monitoring (Procedure), 25 micro-Ci of radiation (Radiation), Assessment of splanchnic capacitance…v5
  9. Notable Lead sponsor: Vanderbilt University to Vanderbilt University Medical Centerv4
  10. Minor Site contacts updated at 1 of 2 sitesv3
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Autoantibody levels
Timeframe: up to 10 minutes
Blood pressure after phenylephrine boluses
Timeframe: 1-2 minutes after bolus injections
Heart rate after isoproterenol boluses
Timeframe: 1-2 minutes after bolus injections
Orthostatic change in heart rate
Timeframe: up to 10 minutes

Secondary (2)

Blood pressure response during phase IV of the Valsalva maneuver
Hear rate response during phase IV of the Valsalva maneuver

Arms and interventions

Autonomic and Antibody AssessmentsExperimental

On up to 3 study days, POTS patients and control subjects will have several tests to assess autonomic function and to detect the presence of autoantibodies to adrenergic receptors. The following tests will de done but in some participants it may not be necessary to do all of them. The investigator will discuss with each participant which particular tests will be done in each particular case: * Posture study with blood samples for autoantibody testing * 24-hour heart rhythm and blood pressure monitoring * autonomic function tests * Quantitative Axonal Sudomotor Reflex Testing * Total blood volume assessment * Pharmacologic testing with phenylephrine * Pharmacologic testing with isoproterenol * Cardiac output with rebreathing * Assessment of splanchnic capacitance * Microneurography

Drugs: phenylephrine, isoproterenol

Radiation: 25 micro-Ci of radiation

Procedures: Posture study with blood samples, 24-hour heart rhythm and blood pressure monitoring, Quantitative Axonal Sudomotor Reflex Testing, Autonomic function tests, microneurography

Other: Rebreathing test, Assessment of splanchnic capacitance

Sites

2 sites in 1 country